Institutional and comprehensive review of laryngeal leukoplakia

Annals of Otology, Rhinology and Laryngology

Volumn 117, Issue 1, 2008, Pages 74-79

  Isenberg, Jason S ^a   Crozier, Daniel L ^a   Dailey, Seth H ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Human; Laryngeal dysplasia; Larynx; Leukoplakia; Vocal fold

Indexed keywords

AGE DISTRIBUTION; DISEASE SEVERITY; DYSPLASIA; HISTOPATHOLOGY; HUMAN; LARYNX; LARYNX LEUKOPLAKIA; LEUKOPLAKIA; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; VOCAL CORD;

EID: 38949212448     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940811700114     Document Type: Review

References (31)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36. [Erratum in CA Cancer J Clin 2001;51:144.]
2. Bouquot JE, Gnepp DR. Laryngeal precancer: a review of the literature, commentary, and comparison with oral leukoplakia. Head Neck 1991;13:488-97.
3. Devaney KO, Rinaldo A, Zeitels SM, Bradley PJ, Ferlito A. Laryngeal dysplasia and other epithelial changes on endoscopic biopsy: what does it all mean to the individual patient? ORL J Otorhinolaryngol Relat Spec 2004;66:1-4.
4. Gallo A, de Vincentiis M, Della Rocca C, et al. Evolution of precancerous laryngeal lesions: a clinicopathologic study with long-term follow-up on 259 patients. Head Neck 2001;23:42-7.
5. Ricci G, Molini E, Faralli M, Simoncelli C. Retrospective study on precancerous laryngeal lesions: long-term follow-up. Acta Otorhinolaryngol Ital 2003;23:362-7.
6. Velasco JR, Suãrez Nieto C, Pedrero de Bustos C, Alvarez Marcos C. Premalignant lesions of the larynx: pathological prognostic factors. J Otolaryngol 1987;16:367-70.
7. Sllamniku B, Bauer W, Painter C, Sessions D. The transformation of keratosis into invasive carcinoma. Am J Otolaryngol 1989;10:42-54.
8. Blackwell KE, Calcaterra TC, Fu YS. Laryngeal dysplasia: epidemiology and treatment outcome. Ann Otol Rhinol Laryngol 1995;104:596-602.
9. Motta G, Esposito E, Motta S, Testa D. Microlaryngoscopy treatment of laryngeal dysplasia with CO2 laser [in Italian]. Acta Otorhinolaryngol Ital 2001;21:32-43.
10. Højslet P-E, Nielsen VM, Palvio D. Premalignant lesions of the larynx. A follow-up study. Acta Otolaryngol 1989;107:150-5.
11. Kalter PO, Lubsen H, Delemarre JFM, Snow GB. Squamous cell hyperplasia of the larynx (a clinical follow-up study). J Laryngol Otol 1987;101:579-88.
12. Gabriel CE, Jones DG. Hyperkeratosis of the larynx. J Laryngol Otol 1973;87:129-34.
13. Hellquist H, Lundgren J, Olofsson J. Hyperplasia, keratosis, dysplasia and carcinoma in situ of the vocal cords - a follow-up study. Clin Otolaryngol Allied Sci 1982;7:11-27.
14. McGavran MH, Bauer WC, Ogura JH. Isolated laryngeal keratosis: its relation to carcinoma of the larynx based on clinicopathologic study of 87 cases with long-term follow-up. Laryngoscope 1960;70:932-51.
15. Crissman JD. Laryngeal keratosis and subsequent carcinoma. Head Neck Surg 1979;1:386-91.
16. Henry RC. The transformation of laryngeal leucoplakia to cancer. J Laryngol Otol 1979;93:447-59.
17. Cuchi A, Bombi JA, Avellaneda R, Cardesa A, Traserra J. Precancerous lesions of the larynx: clinical and pathological correlations and prognostic aspects. Head Neck 1994;16:545-9.
18. Norris CM, Peale AR. Keratosis of the larynx. J Laryngol Otol 1963;77:635-47.
19. Friedmann I. Nose, throat and ears. Edinburgh, Scotland: Churchill Livingstone, 1986.
20. Zeitels SM. Premalignant epithelium and microinvasive cancer of the vocal fold: the evolution of phonomicrosurgical management. Laryngoscope 1995;105(suppl):1-51.
21. Williams HK. Molecular pathogenesis of oral squamous carcinoma. Mol Pathol 2000;53:165-72.
22. Pierce NH. Leucoplakia laryngis. Ann Otol Rhinol Laryngol 1920;29:33-6.
23. Jackson C. Cancer of the larynx: is it preceded by a recognizable precancerous condition? Ann Surg 1923;77:1-14.
24. Bouquot JE, Kurland LT, Weiland LH. Laryngeal keratosis and carcinoma in the Rochester, MN, population, 1935-1984. Cancer Detect Prev 1991;15:83-91.
25. Bauer WC. Concomitant carcinoma in situ and invasive carcinoma of the larynx. Can J Otolaryngol 1974;3:533-42.
26. Visser R, van der Beek JM, Havenith MG, Cleutjens JP, Bosman FT. Immunocytochemical detection of basement membrane antigens in the histopathological evaluation of laryngeal dysplasia and neoplasia. Histopathology 1986;10:171-80.
27. Feng L, Wang Z. Chemopreventive effect of celecoxib in oral precancers and cancers. Laryngoscope 2006;116:1842-5.
28. Wang Z, Polavaram R, Fuentes CF, Shapshay SM. Topical chemoprevention of oral cancer with tretinoin "biofilm." Arch Otolaryngol Head Neck Surg 2003;129:869-73.
29. Franco RA Jr, Zeitels SM, Farinelli WA, Faquin W, Anderson RR. 585-nm Pulsed dye laser treatment of glottal dysplasia. Ann Otol Rhinol Laryngol 2003;112:751-8.
30. Lemaire F, Millon R, Young J, et al. Differential expression profiling of head and neck squamous cell carcinoma (HNSCC). Br J Cancer 2003;89:1940-9.
31. Sok JC, Kuriakose MA, Mahajan VB, Pearlman AN, DeLacure MD, Chen FA. Tissue-specific gene expression of head and neck squamous cell carcinoma in vivo by complementary DNA microarray analysis. Arch Otolaryngol Head Neck Surg 2003;129:760-70.